Strides Pharma Science Limited (NSE:STAR)
816.05
+18.30 (2.29%)
Aug 12, 2025, 3:30 PM IST
Strides Pharma Science Market Cap
Strides Pharma Science has a market cap or net worth of 73.53 billion as of August 12, 2025. Its market cap has decreased by -19.13% in one year.
Market Cap
73.53B
Enterprise Value
90.69B
Revenue
46.31B
Ranking
n/a
PE Ratio
21.50
Stock Price
816.05
Market Cap Chart
Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 73.53B, an increase of 881.20%. That is a compound annual growth rate of 9.35%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 11, 2025 | 73.53B | 20.99% |
Dec 31, 2024 | 60.77B | 1.87% |
Dec 29, 2023 | 59.66B | 88.83% |
Dec 30, 2022 | 31.59B | -21.29% |
Dec 31, 2021 | 40.14B | -49.01% |
Dec 31, 2020 | 78.72B | 142.85% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 3,807.50B |
Divi's Laboratories | 1,570.11B |
Cipla | 1,200.16B |
Apollo Hospitals Enterprise | 1,018.64B |
Mankind Pharma | 1,018.24B |
Zydus Lifesciences | 941.99B |
Fortis Healthcare | 677.46B |
Aurobindo Pharma | 605.25B |